Hereditary Nonpolyposis
1 clinical trials · Condition
◉ Watch Hereditary Nonpolyposis
| Record | Firm | Date |
|---|---|---|
| Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers (NCT00001693) | National Cancer Institute (NCI) | 1998-03-01 |
Track Hereditary Nonpolyposis automatically
Every clearance here is in the API, with alerts when new ones post.